Sponsor Dossier
Chiesi
Sponsor Dossier for Chiesi. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALKINDI
- Brand: ALVESCO
- Brand: ASACOL
- Brand: CLEVIPREX
- Brand: CUROSURF
- Brand: DIACOMIT
- Brand: ELFABRIO
- Brand: ENTOCORT
About
Chiesi is an Australian Private Company with ABN 72 145 180 865, registered in Victoria. The company is active and operates under the trading name Emerge Health.
Portfolio
Chiesi has 15 brands on the ARTG, of which 15 are indexable and 15 carry a Product Information document. 9 brands are PBS-listed, 9 have a PBAC outcome on record, and 8 have an AusPAR on record. Notable brands include ALKINDI, ALVESCO, ASACOL, CLEVIPREX, CUROSURF, DIACOMIT, ELFABRIO, ENTOCORT, FERRIPROX, FILSUVEZ, FOSTAIR, LAMZEDE.
Therapeutic focus
— Respiratory: 5 brands — Endocrinology: 2 brands — Rare Disease: 2 brands — Gastroenterology: 2 brands — Haematology: 1 brand — Neurology: 1 brand — Dermatology: 1 brand — Cardiology: 1 brand
PBS footprint
9 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 9 brands with a PBAC outcome on record. The latest AusPAR is 2026-06-29, across 8 brands with an AusPAR on record.